BAFF&IL17A rHuz bsAb Mixed mAb-scFv (Ref: Tibulizumab)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human
Target
| Target Name | TNFSF13B / BAFF / CD257, IL-17 / IL-17A / CTLA-8 |
| Target Uniprot | Q9Y275 & Q16552 |
Overview
| Catalog# | BIO0947SM |
| Product Name | Anti-human BAFF & IL-17A (Tibulizumab Biosimilar) |
Specifications
| Conjugation | None |
| Clone# | Tibulizumab (Bispecific) |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20°C or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lyophilized |
| Isotype | IgG-scFv |
| Calculated M.W. | 201.44 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |